Sai Life Sciences Share Price: Sai Life Sciences Limited is a leading contract research and manufacturing organization (CRMO) providing services in the pharmaceutical, biotechnology and life sciences sectors. The company specializes in providing integrated solutions in drug discovery, development and manufacturing for global pharmaceutical companies. Here are more details on Sai Life Sciences Stock Price Target 2025, 2026 to 2030.
Sai Life Sciences Company Overview
| Company Name | Sai Life Sciences Ltd. |
| Founded | 1999 |
| Headquarters | Hyderabad |
| Industry | Pharmaceutical |
| Chairman | K. Ranga Raju |
| Stock Exchange Listing | NSE & BSE |
| Official Website | sailife.com |
Sai Life Sciences Fundamental Analysis
| Metric | Value |
|---|---|
| Market Cap | ₹15,523.30 Cr. |
| ROE | 10.01% |
| ROCE | 12.61% |
| P/E | 163.01 |
| P/B | 2.72 |
| Div. Yield | 0% |
| Book Value | ₹274.03 |
| Face Value | ₹1 |
| EPS (TTM) | ₹4.58 |
| 52 Week High | ₹802 |
| 52 Week Low | ₹651.20 |
Also Read: Tata Investment Share Price Target
Sai Life Sciences Financials
Income Statement
| (INR) | 2024 | Y/Y change |
|---|---|---|
| Revenue | 14.65B | 20.38% |
| Operating expense | 8.08B | 18.13% |
| Net income | 828.09M | 729.00% |
| Net profit margin | 5.65 | 589.02% |
| Earnings per share | — | — |
| EBITDA | 2.45B | 94.52% |
| Effective tax rate | 24.19% | — |
Balance Sheet
| (INR) | 2024 | Y/Y change |
|---|---|---|
| Cash and short-term investments | 1.85B | -9.88% |
| Total assets | 22.75B | 4.05% |
| Total liabilities | 13.00B | 0.11% |
| Total equity | 9.75B | — |
| Shares outstanding | 183.92M | — |
| Price to book | 13.83 | — |
| Return on assets | 4.83% | — |
| Return on capital | 5.78% | — |
Cash Flow
| (INR) | 2024 | Y/Y change |
|---|---|---|
| Net income | 828.09M | 729.00% |
| Cash from operations | 2.63B | 19.91% |
| Cash from investing | -1.92B | -89.01% |
| Cash from financing | -952.99M | 52.50% |
| Net change in cash | -235.60M | 70.64% |
| Free cash flow | -254.97M | -1,211.34% |
Also Read: Share India Securities Share Price Target
Sai Life Sciences Share Price Target From 2025 to 2030
| Year | Target Price |
|---|---|
| Sai Life Sciences Share Price Target​ 2025 | ₹915 |
| Sai Life Sciences Share Price Target 2026 | ₹1,090 |
| Sai Life Sciences Share Price Target 2027 | ₹1,265 |
| Sai Life Sciences Share Price Target 2028 | ₹1,390 |
| Sai Life Sciences Share Price Target 2029 | ₹1,535 |
| Sai Life Sciences Share Price Target 2030 | ₹1,640 |
Sai Life Sciences Shareholding Pattern
- Retail & Other: 51.77%
- Promoters: 35.24%
- Foreign Institutions: 7.64%
- Mutual Funds: 4.24%
- Other Domestic Institutions: 1.12%
Also Read: Vishal Mega Mart Share Price Target
Sai Life Sciences Competitors/Peer Companies
- Torrent Pharmaceuticals
- Ajanta Pharma
- Gland Pharma
- Eris Lifesciences
- Caplin Point Laboratories
- Marksans Pharma
- Shilpa Medicare
- Jeena Sikho Lifecare
- Windlas Biotech
- Amrutanjan Health Care
Also Read: Mobikwik Share Price Target
To connect with us, click on any of the given social media buttons.
FAQs
-
What is the Sai Life Sciences Target Price in 2025?
In 2025, Sai Life Sciences is expected to see significant growth in its contract manufacturing business. Pharmaceutical companies worldwide are increasingly looking to outsource their operations, bolstering Sai Life Sciences’ position as a leading CRDMO player. Cutting-edge technologies, like AI-driven drug development, will be crucial. Consequently, the target share price for 2025 is set at 600 INR per share.
-
What is the Sai Life Sciences Target Price in 2026?
By the year 2026, the target share price for this will be 750 INR per share. 2026, Sai Life Sciences is anticipated to expand its presence in Europe and North America, strengthening its foothold through strategic collaborations and smart deals. The rising demand for pharmaceuticals in these regions, coupled with the company’s focus on high-quality production, will drive growth.
-
What is the Sai Life Sciences Target Price in 2027?
The stock price target for 2027 is 850 INR as the company continues to build its assets. With advancements in biotechnology and a growing preference for biologics and biosimilars, Sai Life Sciences is poised to benefit significantly in 2027. The company will likely see increased revenue by focusing on manufacturing for these high-growth markets.
-
What is the Sai Life Sciences Target Price in 2029?
As the company strengthens its global footprint, the share prediction for 2029 is 1,150 INR per share. In 2029, Sai Life Sciences will focus on expanding its global market, especially in emerging regions like Africa and Latin America. The growing need for high-quality, affordable medicines in these areas will drive growth.
-
What is the Sai Life Sciences Target Price in 2030?
The share price prediction for 2030 is 1,300 INR per share. By this year Sai Life Sciences is expected to be among the best in developing and manufacturing complex APIs and formulations. With extensive experience in regulatory compliance, particularly in developed markets, the company will form strategic partnerships with ease.
Disclaimer: The information in this blog is for educational purposes only, and the targets mentioned in it are given as suggestions by market analysts. Therefore, before investing your money in any company, it is mandatory to get complete information about the company and consult your financial advisor.
I am a content writer and financial analyst with deep knowledge of mutual funds and the stock market. My focus is always on delivering authentic, reader-first content.